Publications
Taking STRIDES: The value of diagnostics against AMR
10 June 2025
Addressing a critical gap in AMR policy and evaluation Antimicrobial resistance…
Altering the trajectory of HIV in Europe
22 May 2025
Despite substantial medical advancements that have transformed HIV into a…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
Long-acting (LA) therapies represent a significant innovation in pharmaceutical…
An Analysis of NICE’s Optimised Decisions from 2015 to 2024
1 May 2025
The National Institute for Health and Care Excellence (NICE) is the body…
Insights
Reflections from the Region: Healthcare transformation in the Middle East
18 June 2025
It’s not often that you witness a health system reinvent itself in real-time.…
The Trump Administration’s US Drug Pricing Proposal – What will happen next?
12 June 2025
This is the second in our series of Insights considering the implications of…
How Widely Are QALYs Used in OECD Countries? A Snapshot of International Practices
11 June 2025
As healthcare systems strive to allocate resources efficiently, the use of…
Around the world in HTAs: Argentina – Long Road to Institutionalizing HTA
9 June 2025
In this Insights series, Around the World in HTAs, we shed light on HTA around…
Robust analysis, real-world problems
OHE research supports pragmatic solutions and stronger policy decisions
Areas of expertise
OHE’s expertise covers a wide range of topics
Health Technology Assessment (HTA)
Reflections from the Region: Healthcare transformation in the Middle East
It’s not often that you witness a health system reinvent itself in real-time. And yet, this is precisely what is…
How Widely Are QALYs Used in OECD Countries? A Snapshot of International Practices
As healthcare systems strive to allocate resources efficiently, the use of economic evaluation metrics like…
Drug Development/R&D
The Trump Administration’s US Drug Pricing Proposal – What will happen next?
This is the second in our series of Insights considering the implications of President Trump’s Executive Order on ‘Most…
Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines
Join us for an online CERSI-PGx Health Economics Workshop on 10 June 2025, from 13:00–17:00 BST, with experts from NHS…
Digital Health
OHE’s submission for the DHSC’s next 10 years of planning
This Insight summarises the recommendations OHE submitted towards the Department of Health & Social Care’s consultation…
Green Healthcare: Are We Asking the Right Questions?
The climate-health crisis is a growing global concern, and identifying the right starting points is crucial.
Prevention
Valuing health in an era of climate crisis: informing policy through economic evidence
This panel brings together leading researchers to explore how health economics can inform policy design in the context of…
Reflections from the Region: Healthcare transformation in the Middle East
It’s not often that you witness a health system reinvent itself in real-time. And yet, this is precisely what is…